Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
[dedifferentiated liposarcoma]
Although
sarcoma
histology
is
recognized
as
a
prognostic
factor
,
most
studies
of
retroperitoneal
sarcomas
report
results
combining
multiple
histologies
and
are
inadequately
powered
to
identify
prognostic
factors
specific
to
a
particular
histology
.
We
reviewed
our
experience
with
retroperitoneal
dedifferentiated
liposarcoma
(
RP
DDLPS
)
to
identify
factors
predictive
of
outcomes
.
All
patients
with
RP
DDLPS
treated
at
our
institution
between
1998
and
2008
were
reviewed
.
Multivariable
Cox
regression
analyses
were
performed
to
identify
factors
predictive
of
progression-free
survival
(
PFS
)
,
local
recurrence-free
survival
(
LRFS
)
,
distant
recurrence-free
survival
(
DRFS
)
,
and
overall
survival
(
OS
)
.
We
identified
119
patients
with
primary
DDLPS
.
Median
tumor
size
was
20
.
5
cm
;
21
%
were
multifocal
.
French
Federation
of
Cancer
Centers
Sarcoma
Group
tumor
grades
were
intermediate
in
53
%
of
patients
and
high
in
28
%
(
unknown
19
%
)
.
Resections
were
complete
(
R
0
/
R
1
)
in
80
%
of
patients
and
incomplete
(
R
2
)
in
11
%
(
unknown
9
%
)
.
Tumors
were
removed
intact
in
72
%
of
patients
and
fragmented
in
16
%
(
unknown
12
%
)
.
Median
follow-up
was
74
.
1
months
.
One
hundred
patients
(
84
%
)
experienced
recurrence
or
progression
,
with
92
%
occurring
in
the
retroperitoneum
.
Median
PFS
,
LRFS
,
DRFS
,
and
OS
were
21
.
1
,
21
.
5
,
45
.
8
,
and
59
.
0
months
,
respectively
,
and
were
significantly
worse
with
R
2
resection
.
On
multivariate
analysis
,
tumor
integrity
(
intact
vs
fragmented
)
was
predictive
of
PFS
,
multifocality
predicted
LRFS
,
and
extent
of
resection
(
R
0
/
R
1
vs
R
2
)
,
grade
,
and
tumor
integrity
predicted
OS
.
In
this
cohort
of
primary
RP
DDLPS
,
factors
under
surgeon
control
(
tumor
integrity
,
extent
of
resection
)
and
reflective
of
tumor
biology
(
grade
,
multifocality
)
impact
patient
outcomes
.
Diseases
Validation
Diseases presenting
"cancer"
symptom
achondroplasia
acute rheumatic fever
adrenal incidentaloma
alpha-thalassemia
benign recurrent intrahepatic cholestasis
cadasil
canavan disease
carcinoma of the gallbladder
cholangiocarcinoma
coats disease
congenital adrenal hyperplasia
congenital diaphragmatic hernia
cowden syndrome
cushing syndrome
cutaneous mastocytosis
dedifferentiated liposarcoma
dystrophic epidermolysis bullosa
epidermolysis bullosa simplex
erdheim-chester disease
erythropoietic protoporphyria
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
familial hypocalciuric hypercalcemia
familial mediterranean fever
gm1 gangliosidosis
heparin-induced thrombocytopenia
hereditary cerebral hemorrhage with amyloidosis
hirschsprung disease
hodgkin lymphoma, classical
inclusion body myositis
junctional epidermolysis bullosa
kabuki syndrome
kallmann syndrome
kindler syndrome
lamellar ichthyosis
liposarcoma
locked-in syndrome
lymphangioleiomyomatosis
monosomy 21
neuralgic amyotrophy
oculocutaneous albinism
oligodontia
oral submucous fibrosis
papillon-lefèvre syndrome
pendred syndrome
pleomorphic liposarcoma
primary effusion lymphoma
proteus syndrome
pyomyositis
pyruvate dehydrogenase deficiency
severe combined immunodeficiency
sneddon syndrome
systemic capillary leak syndrome
triple a syndrome
von hippel-lindau disease
waldenström macroglobulinemia
well-differentiated liposarcoma
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
This symptom has already been validated